Literature DB >> 23575988

Childhood infectious diseases and risk of leukaemia in an adult population.

Stefano Parodi1, Paolo Crosignani, Lucia Miligi, Oriana Nanni, Valerio Ramazzotti, Stefania Rodella, Adele Seniori Costantini, Rosario Tumino, Carla Vindigni, Paolo Vineis, Emanuele Stagnaro.   

Abstract

Our study is aimed at investigating the association between common childhood infectious diseases (measles, chickenpox, rubella, mumps and pertussis) and the risk of developing leukaemia in an adult population. A reanalysis of a large population-based case-control study was carried out. Original data included 1,771 controls and 649 leukaemia cases from 11 Italian areas. To contain recall bias, the analysis was restricted to subjects directly interviewed and with a good quality interview (1,165 controls and 312 cases). Odds ratios (ORs) and their related 95% confidence intervals (95% CIs) were estimated by unconditional polychotomous logistic regression model adjusting for age, gender and occupational and lifestyle exposures. A protective effect of at least one infection (OR = 0.66, 95% CI: 0.45-0.97), measles (OR = 0.57, 95% CI: 0.39-0.82) and pertussis (OR = 0.66, 95% CI: 0.45-0.98) was observed for chronic lymphoid leukaemia (CLL). The number of infections was strongly inversely associated with the risk of CLL (p = 0.002, test for trend). With regard to the other types of leukaemia, only a protective effect of pertussis was observed for AML (OR = 0.52, 95% CI: 0.32-0.87). Our results pointed out a protective role of childhood infectious diseases on the risk of CLL in adults. Although a specific antioncogenic effect of some infectious disease, especially measles, cannot be ruled out, the observed decrease of risk with increasing number of infections suggests that a more general "hygiene hypothesis" could be the most likely explanation of the detected association. The protective role of pertussis remains to be elucidated.
Copyright © 2013 UICC.

Entities:  

Keywords:  case-control study; infectious diseases; leukaemia; measles; pertussis

Mesh:

Year:  2013        PMID: 23575988     DOI: 10.1002/ijc.28205

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

Review 1.  Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention.

Authors:  Camille Jacqueline; Olivera J Finn
Journal:  Semin Immunol       Date:  2020-04-06       Impact factor: 11.130

2.  Complete Regression of Rhabdomyosarcoma in an Adult Secondary to Postoperative Wound Infection Following Limb Salvage Surgery: A Case Report.

Authors:  Andrew S Fang; Lee Jae Morse; Rosanna Wustrack; Ryan Huber; Minggui Pan
Journal:  Perm J       Date:  2020-12

3.  Childhood infectious diseases and risk of multiple myeloma: an analysis of the Italian multicentre case-control study.

Authors:  E Stagnaro; S Parodi; A Seniori Costantini; P Crosignani; L Miligi; O Nanni; S Piro; V Ramazzotti; S Rodella; R Tumino; C Vindigni; P Vineis
Journal:  Epidemiol Infect       Date:  2018-05-30       Impact factor: 4.434

Review 4.  The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies.

Authors:  Bernd Krone; Klaus F Kölmel; John M Grange
Journal:  BMC Cancer       Date:  2014-08-16       Impact factor: 4.430

5.  Infections and cancer: the "fifty shades of immunity" hypothesis.

Authors:  Camille Jacqueline; Aurélie Tasiemski; Gabriele Sorci; Beata Ujvari; Fatima Maachi; Dorothée Missé; François Renaud; Paul Ewald; Frédéric Thomas; Benjamin Roche
Journal:  BMC Cancer       Date:  2017-04-12       Impact factor: 4.430

6.  AllergoOncology: Microbiota in allergy and cancer-A European Academy for Allergy and Clinical Immunology position paper.

Authors:  Eva Untersmayr; Heather J Bax; Christoph Bergmann; Rodolfo Bianchini; Wendy Cozen; Hannah J Gould; Karin Hartmann; Debra H Josephs; Francesca Levi-Schaffer; Manuel L Penichet; Liam O'Mahony; Aurelie Poli; Frank A Redegeld; Franziska Roth-Walter; Michelle C Turner; Luca Vangelista; Sophia N Karagiannis; Erika Jensen-Jarolim
Journal:  Allergy       Date:  2019-03-06       Impact factor: 13.146

7.  LCVM infection generates tumor antigen-specific immunity and inhibits growth of nonviral tumors.

Authors:  Camille Jacqueline; Matthew Dracz; Jia Xue; Robert J Binder; Jonathan Minden; Olivera Finn
Journal:  Oncoimmunology       Date:  2022-01-21       Impact factor: 7.723

Review 8.  Villains or heroes? The raison d'être of viruses.

Authors:  Tokiko Watanabe; Yoshihiro Kawaoka
Journal:  Clin Transl Immunology       Date:  2020-02-19

Review 9.  Pertussis in Individuals with Co-morbidities: A Systematic Review.

Authors:  Denis Macina; Keith E Evans
Journal:  Infect Dis Ther       Date:  2021-06-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.